BioWorld

Oct. 5, 2006

View Archived Issues

Plexxikon Enters Roche Deal On B-Raf Inhibitors For $706M

Earlier this week, Plexxikon Inc.'s president Kathleen Sereda Glaub told BioWorld Today that the company was in "active partnering mode." (BioWorld Today) Read More

Genentech, CGI In Potential $500M Kinase-Focused Deal

Read More

Killing Bacterial Gang Of Four Can Divide, Conquer Biofilms

Read More

HGS Updates Pipeline, Unveils Albuferon Phase III HCV Plans

Read More

Capitalizing On Stock Boost, Acorda Raises $32M Privately

Read More

Clinic Roundup

Read More

Other News To Note

Read More